LabCentral、C10 Labs 与丹麦创新中心波士顿举办 Entangled 2026 峰会，聚焦量子计算、AI 与生物科技融合

LabCentral, C10 Labs and Innovation Centre Denmark Boston host cross-sector event to examine how emerging technologies and human collaboration could shape the next wave of scientific discovery

, /PRNewswire/ -- LabCentral, C10 Labs and Innovation Centre Denmark Boston today announced Entangled 2026, a summit taking place November 19 at The Platform in Cambridge's Kendall Square. Centered on the question, "What makes the next breakthrough possible?", the event will bring together a set of leaders across artificial intelligence (AI), quantum computing, biotech and other disciplines to examine how advances in AI and quantum computing, combined with purposeful cross-sector collaboration, can create new opportunities for scientific innovation and impact.

The summit takes its name from quantum entanglement, the phenomenon in which particles remain connected regardless of the distance between them, a premise organizers believe applies to scientific progress as well: it won't happen in isolation.

The day-long summit will convene a curated audience of more than 250 leaders from biotech, deep tech, investment, academia and government, including a delegation of approximately 50 representatives from Denmark. As AI and quantum computing reshape scientific research and drug discovery, Entangled will focus on the expertise, partnerships and resources needed to turn technological advances into tangible scientific progress. The program will feature a keynote by Ebba Carbonnier, CEO of QuNorth, on the company's efforts to build one of the world's most powerful quantum computers, a panel with Eric Paley, secretary of economic development for the Commonwealth of Massachusetts, and discussions with leading researchers, entrepreneurs, investors and industry executives.

"Massachusetts has long been a global leader in life sciences innovation, and the next chapter will be shaped by how readily we embrace new technologies and connect expertise across disciplines, sectors and borders," said Kamran Tavangar, head of science strategy & partnerships at LabCentral. "As AI and quantum computing take on a larger role in scientific discovery, we have an opportunity to build on the Commonwealth's strengths by helping entrepreneurs access the expertise and resources needed to harness these technologies and translate breakthroughs from the lab into real-world applications."

"The convergence of AI, quantum computing and biotech is opening up exciting opportunities for entrepreneurs and investors alike," said Shahid Azim, co-founder, CEO and managing partner of C10 Labs. "But realizing that potential takes more than promising technology. It requires connecting scientific expertise with entrepreneurial talent, capital and the right partners to build and scale the next generation of innovative companies. Entangled is our vision to bring these communities together and help forge lasting relationships that extend beyond the summit."

"The future of scientific innovation depends more than ever on our ability to collaborate across disciplines, industries and international borders," said Bjarke Stoltze Kaspersen, Science Attaché, Innovation Centre Denmark Boston. "With Denmark's growing commitment to quantum technology and the strong life sciences ecosystems in both Denmark and Massachusetts, there is tremendous potential to connect researchers, companies and innovation leaders across our two regions and advance scientific discovery."

The Entangled 2026 program will include discussions on building AI and quantum innovation ecosystems, using emerging technologies to develop and move scientific discoveries toward real-world impact, evaluating investment potential and advancing drug discovery through partnerships between startups, academia and the pharmaceutical industry. The day will conclude with a digital poster showcase featuring more than 20 startups, research teams and deep tech organizations.

View the full Entangled 2026 agenda or apply to attend the summit. 

About LabCentral
A private, non-profit institution, LabCentral is a launchpad for high-potential life sciences and biotech start-ups with more than 200,000 square feet of space across Kendall Square in Cambridge, Mass., and the Harvard University campus. Founded in 2013, LabCentral offers a full complement of programming and networking to life sciences entrepreneurs in addition to fully permitted laboratory and office space for early-stage and growing life sciences companies. In its first twelve years, LabCentral residents raised more than $21 billion in funding and created more than 7,800 jobs. More information is available at www.labcentral.org. 

About C10 Labs
C10 Labs, located in Cambridge & New York City, is a venture fund and studio dedicated to reshaping the landscape of AI-first startups. We collaborate with visionary entrepreneurs to advance and expand their ventures. By providing our teams with comprehensive technological support, operational expertise, and access to a distinguished network of advisors, we collectively amplify our impact. More Information available at www.c10labs.com. 

About Innovation Centre Denmark Boston
Innovation Centre Denmark (ICDK) Boston is part of Denmark's global network of eight innovation centers and a partnership between the Ministry of Foreign Affairs of Denmark and the Ministry of Science, Higher Education and Digital Affairs. ICDK Boston bridges the Danish and US innovation ecosystems, leveraging Greater Boston and Massachusetts' world-class research and technology landscape to connect companies, researchers, investors and leading institutions. By bringing together key stakeholders and fostering strategic partnerships, ICDK Boston helps translate knowledge and innovation into commercial opportunities and international growth.

SOURCE LabCentral